Health Prob Civil.
1. Wolnicka K. The role of nutrition in oncological prevention. NOWOTWORY J Oncol. 2024; 74: 57-65. https://doi.org/10.5603/njo.98446.
2.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2021; 71(3): 209-249. https://doi.org/10.3322/caac.21660.
3.
National Cancer Register. Raports [Internet]. Warsaw: National Cancer Register [access 2024 Feb 26]. Available from: https://onkologia.org.pl/pl/raporty (in Polish).
4.
Sulkowska U, Michałek I, Wojciechowska U, Olasek P, Orzechowska M, Natkańska S, et al. Cancer in mazowieckie voivodeship in 2021 [Internet]. Warsaw: PMaria Sklodowska-Curie National Research Institute of Oncology; 2023 [access 2024 Feb 26]. Available from: http://mrn.pib-nio.pl/wp-content/uploads/2024/01/MRN-2023.pdf (in Polish).
5.
Pyun JH, Ko YH, Kim SW, Son N-H. The Short- and long-term anticipation of prostate cancer incidence in Korea: based on social aging trends and prostate-specific antigen testing rate during the last decade. Cancers. 2024; 16(3): 503. https://doi.org/10.3390/cancers16030503
6.
Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019; 10(2): 63-89. https://doi.org/10.14740/wjon1191
7.
Malik SS, Batool R, Masood N, Yasmin A. Risk factors for prostate cancer: a multifactorial case-control study. Curr. Probl. Cancer. 2018; 42: 337-343. https://doi.org/10.1016/j.currproblcancer.2018.01.014
8.
Jung KW, Won YJ, Kang MJ, Kong HJ, Im JS, Seo HG. Prediction of cancer incidence and mortality in Korea, 2022. Cancer Research and Treatment: Official Journal of Korean Cancer Association. 2022; 54(2): 345-351. https://doi.org/10.4143/crt.2022.179
9.
GBD 2019 Cancer Risk Factors Collaborators. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022; 400(10352): 563-591. https://doi.org/10.1016/S0140-6736(22)01438-6
10.
Oczkowski M, Dziendzikowska K, Pasternak-Winiarska A, Włodarek D, Gromadzka-Ostrowska J. Dietary factors and prostate cancer development, progression, and reduction. Nutrients. 2021; 13(2): 496. https://doi.org/10.3390/nu13020496
11.
Matsushita M, Fujita K, Nonomura N. Influence of diet and nutrition on prostate cancer. Int J Mol Sci. 2020; 21(4): 1447. https://doi.org/10.3390/ijms21041447
12.
Wang K, Chen X, Bird VY, Gerke TA, Manini TM, Prosperi M. Association between age‐related reductions in testosterone and risk of prostate cancer – an analysis of patients' data with prostatic diseases. International Journal of Cancer. 2017; 141(9): 1783-1793. https://doi.org/10.1002/ijc.30882
13.
Carlsson S, Assel M, Ulmert D, Gerdtsson A, Hugosson J, Vickers A, et al. Screening for prostate cancer starting at age 50-54 years. A population-based cohort study. European Urology. 2017; 71(1): 46-52. https://doi.org/10.1016/j.eururo.2016.03.026
14.
Parker C, Castro E, Fizazi K, Heidenreich A, Ost P, Procopio G, et al. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2020; 31(9): 1119-1134. https://doi.org/10.1016/j.annonc.2020.06.011
15.
Bhuyan SS, Chandak A, Gupta N, Isharwal S, LaGrange C, Mahmood A, et al. Gentry D. Patient–provider communication about prostate cancer screening and treatment: new evidence from the Health Information National Trends Survey. American Journal of Men's Health. 2017; 11(1): 134-146. https://doi.org/10.1177/1557988315614082
16.
Saman DM, Harry ML, Freitag LA, Allen CI, O'Connor PJ, Sperl-Hillen JM, et al. Patient perceptions of using clinical decision support for cancer screening and prevention: "I wouldn't have thought about getting screened without it.". J Patient Cent Res Rev. 2021; 8(4): 297-306. https://doi.org/10.17294/2330-0698.1863
17.
Kannan A, Kirkman M, Ruseckaite R, Evans SM. Prostate cancer awareness, case-finding, and early diagnosis: interviews with undiagnosed men in Australia. PLoS One. 2019; 14(3): e0211539. https://doi.org/10.1371/journal.pone.0211539
18.
World Medical Association. Declaration of Helsinki. JAMA. 2013; 310(20): 2191. https://doi.org/10.1001/jama.2013.281053
19.
Gift S, Nancy K, Victor M. Assessment of knowledge, practice and attitude towards prostate cancer screening among male patients aged 40 years and above at Kitwe Teaching Hospital, Zambia. African Journal of Urology. 2020; 26(70): 1-7. https://doi.org/10.1186/s12301-020-00067-0
20.
Ukoli FA, Patel K, Hargreaves M, Beard K, Moton PJ, Bragg R, et al. A tailored prostate cancer education intervention for low-income African Americans: impact on knowledge and screening. Journal of Health Care for the Poor and Underserved. 2013; 24(1): 311-331. https://doi.org/10.1353/hpu.2013.0033
21.
Bilgili N, Kitiş Y. Prostate cancer screening and health beliefs: a Turkish study of male adults. J Clin Pract Res. 2019; 41(2): 164-169. https://doi.org/10.14744/etd.2019.45762
22.
Asare BY, Ackumey MM. Awareness and knowledge about prostate cancer among male teachers in the Sunyani Municipality, Ghana. Afr Health Sci. 2021; 21(2): 655-662. https://doi.org/10.4314/ahs.v21i2.22
23.
Ojewola RW, Oridota ES, Balogun OS, Ogundare EO, Alabi TO, Banjo OO, et al. Knowledge, attitudes and screening practices regarding prostatic diseases among men older than 40 years: a population-based study in Southwest Nigeria. Pan Afr Med J. 2017; 27: 151. https://doi.org/10.11604/pamj.2017.27.151.10605
24.
Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, et al. SEER Cancer Statistics Review, 1975-2014 [Internet]. Bethesda, MD: National Cancer Institute; 2018 [access 2024 Feb 22]. Available from: https://seer.cancer.gov/csr/1975_2014/
25.
Deluga A, Ślusarska B, Belmas E, Charzyńska-Gula M. [Men’s knowledge on risk factors of prostate cancer]. Probl Hig Epidemiol. 2015; 96(4): 757-762 (in Polish).
26.
Kohestani K, Chilov M, Carlsson SV. Prostate cancer screening-when to start and how to screen?. Transl Androl Urol. 2018; 7(1): 34-45. https://doi.org/10.21037/tau.2017.12.25
27.
Stattin P, Vickers AJ, Sjoberg DD, Johansson R, Granfors T, Johansson M, et al. Improving the specificity of screening for lethal prostate cancer using prostate-specific antigen and a panel of kallikrein markers: a nested case-control study. Eur Urol. 2015; 68(2): 207-13. https://doi.org/10.1016/j.eururo.2015.01.009
28.
Carlsson S, Assel M, Ulmert D, Gerdtsson A, Hugosson J, Vickers A, et al. Screening for prostate cancer starting at age 50-54 years. A population-based cohort study. European Urology. 2017; 71(1): 46-52. https://doi.org/10.1016/j.eururo.2016.03.026
29.
Sosnowski R, Kuczkiewicz O, Moskal K, Kuncewicz P. [Assessing men's knowledge of lower urinary tract symptoms]. Przegląd Urologiczny. 2017; 5(105) (in Polish).
30.
Morlando M, Pelullo CP, Di Giuseppe G. Prostate cancer screening: knowledge, attitudes and practices in a sample of men in Italy. A survey. PloS One. 2017; 12(10): e0186332. https://doi.org/10.1371/journal.pone.0186332.
31.
Braga R, Costa AR, Pina F, Moura-Ferreira P, Lunet N. Prostate cancer screening in Portugal: prevalence and perception of potential benefits and adverse effects. Eur J Cancer Prev. 2020; 29(3): 248-251. https://doi.org/10.1097/CEJ.0000000000000539
32.
Snijders RAH, Brom L, Theunissen M, van den Beuken-van Everdingen MHJ. Update on prevalence of pain in patients with cancer 2022: a systematic literature review and meta-analysis. Cancers. 2023; 15(3): 591. https://doi.org/10.3390/cancers15030591
33.
Sanford NN, Sher DJ, Butler SS, Xu X, Ahn C, Aizer AA, et al. Prevalence of chronic pain among cancer survivors in the United States, 2010-2017. Cancer. 2019; 125(23): 4310-4318. https://doi.org/10.1002/cncr.32450
34.
Ngowi BN, Mremi A, Mbwambo OJ, Mitao MP, Nyindo M, Mteta KA, et al. Prostate cancer knowledge and barriers to screening among men at risk in northern Tanzania: a community-based study. Cancer Treatment and Research Communications. 2024: 100811. https://doi.org/10.1016/j.ctarc.2024.100811
35.
Coughlin SS, Vernon M, Klaassen Z, Tingen MS, Cortes JE. Knowledge of prostate cancer among African American men: a systematic review. The Prostate. 2021; 81(3): 202-213. https://doi.org/10.1002/pros.24097
36.
Nationale-Nederlanden. [Cancer] [Internet]. [access 2024 Feb 26]. Available from: https://www.nn.pl/dam/jcr:2f1b848b-47c0-476b-87fb-69b948ef748f/Rak-Nationale-Nederlanden-Miej-serce-do-zdrowia-Raport-Zdrowotny.pdf (in Polish).
37.
Ahmad MM, Musallam R, Allah AH, Al-Daken L, Abu-Snieneh H, Al-Dweik G. Maturity level of the stigma concept associated with cancer diagnosis in the nursing literature. Asian Pacific Journal of Cancer Prevention. 2018; 19(2): 479-485. https://doi.org/10.22034/APJCP.2018.19.2.479
38.
Appleton L, Wyatt D, Perkins E, Parker C, Crane J, Jones A. The impact of prostate cancer on men’s everyday life. Eur J Cancer Care (Engl). 2015; 24(1): 71-84. https://doi.org/10.1111/ecc.12233
39.
Chambers SK, Lowe A, Hyde MK, Zajdlewicz L, Gardiner RA, Sandoe D, et al. Defining young in the context of prostate cancer. Am J Mens Health. 2015; 9(2): 103-114. https://doi.org/10.1177/1557988314529991
40.
Ussher JM, Perz J, Rose D, Dowsett GW, Chambers S, Williams S, et al. Threat of sexual disqualification: the consequences of erectile dysfunction and other sexual changes for gay and bisexual men with prostate cancer. Arch Sex Behav. 2017; 46(7): 2043-2057. https://doi.org/10.1007/s10508-016-0728-0
41.
Ettridge KA, Bowden JA, Chambers SK, Smith DP, Murphy M, Evans SM, et al. “Prostate cancer is far more hidden…”: Perceptions of stigma, social isolation and help‐seeking among men with prostate cancer. European Journal of Cancer Care. 2017; 27(2): e12790. https://doi.org/10.1111/ecc.12790
42.
Ogunsanya ME, Brown CM, Odedina FT, Barner JC, Corbell B, Adedipe TB. Beliefs regarding prostate cancer screening among black males aged 18 to 40 years. American Journal of Men’s Health. 2017; 11(1): 41-53. https://doi.org/10.1177/1557988316637879
43.
Bansal A, Koepl LM, Fedorenko CR, Li C, Smith JL, Hall IJ, et al. Information seeking and satisfaction with information sources among spouses of men with newly diagnosed local-stage prostate cancer. J Canc Educ. 2018; 33: 325-331. https://doi.org/10.1007/s13187-017-1179-6
44.
Hicks EM, Litwin MS, Maliski SL. Latino men and familial risk communication about prostate cancer. Oncol Nurs Forum. 2014; 41(5): 509-516. https://doi.org/10.1188/14.ONF.509-516
45.
Okoro ON, Rutherford CA, Witherspoon SF. Leveraging the family influence of women in prostate cancer efforts targeting African American men. J. Racial and Ethnic Health Disparities. 2018; 5: 820-830. https://doi.org/10.1007/s40615-017-0427-0
46.
Martinez-Lopez N, Makarov DV, Thomas J, Ciprut S, Hickman T, Cole H, et al. A study to compare a CHW-Led versus physician-led intervention for prostate cancer screening decision-making among black men. Ethnicity & Disease. 2023; 33(1): 26-32. https://doi.org/10.18865/1722
47.
Pucheril D, Fletcher SA, Zlatev DV, Mossanen M, Ingham MD, Chang SL, et al. Shared decision making for prostate cancer screening: Reality or farce?. JCO. 2018; 36: 107-107. https://doi.org/10.1200/JCO.2018.36.6_suppl.107
48.
Bennett C, Davis ID, Hamid AA. Nursing implications of recent changes in management practices for metastatic prostate cancer. Seminars in Oncology Nursing. 2020; 36(4): 151047. https://doi.org/10.1016/j.soncn.2020.151047
49.
Molazem Z, Ebadi M, Khademian M, Zare R. Effects of an educational program for prostate cancer prevention on knowledge and psa testing in men over 50 years old in community areas of Shiraz in 2016. Asian Pac J Cancer Prev. 2018; 19(3): 633-637. https://doi.org/10.22034/APJCP.2018
50.
Zare M, Ghodsbin F, Jahanbin I, Ariafar A, Keshavarzi S, Izadi T. The effect of health belief model-based education on knowledge and prostate cancer screening behaviors: a randomized controlled trial. Int J Community Based Nurs Midwifery. 2016; 4(1): 57-68.
Copyright: © 2024 Pope John Paul II State School of Higher Education in Biała Podlaska. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
